Innatoss Laboratories is a fast growing company in vitro diagnostics. Because of the development of new tests, obtaining international assignments and grants, and the strong focus on a very limited number of infectious diseases, Innatoss has been able to obtain an expert position in a very short period of time. Our nomination as Challenger 50, one of the fifty most innovative companies in the Netherlands in 2016, by Sprout and the Q-VaxCelerate assignment of MGH is a reflection of this.
Information for interested investors
Interested investors can contact our CEO Anja Garritsen for more information. This can be done via the general phone number +31412 7000 507.